State Street’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
NCNMGF
FCM
SAM
KCM
MBAM
State Street's XGN Position: Q2 2026 in Review
State Street held its Exagen (XGN) position steady in Q2 2026 at 71,256 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #3686.
State Street first reported a position in XGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.73M in Q3 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.
- State Street held 71,256 shares of Exagen worth $331K as of Q2 2026.
- State Street left its Exagen share count unchanged in Q2 2026.
- Exagen made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3686 holding.
- State Street first reported a position in Exagen in Q4 2019 and has held it in 27 quarters since.
- State Street's Exagen position peaked at $1.73M in Q3 2021.
- 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.